3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
30
Oropharyngeal Neoplasms
21
Nasopharyngeal Carcinoma
15
Head and Neck Neoplasms
13
Prostatic Neoplasms
11
Laryngeal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Carcinoma, Squamous Cell
8
Carcinoma
8
Breast Neoplasms
8
Rectal Neoplasms
7
Mouth Neoplasms
7
Hypopharyngeal Neoplasms
7
Glioma
6
Glioblastoma
6
Uterine Cervical Neoplasms
5
Papillomavirus Infections
5
Esophageal Neoplasms
5
Urinary Bladder Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Nasopharyngeal Neoplasms
4
Astrocytoma
4
Mesothelioma, Malignant
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Tumor Virus Infections
2
Tongue Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Interventions
Bevacizumab
2
neratinib
1
brigatinib
1
Sufentanil
1
Radiosurgery
1
Mn-PyC3A
1
Losartan
1
HDAC-42
1
Cochlear Implants
1
Aspirin
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroma, Acoustic
×
Radiotherapy, Intensity-Modulated
×
1 year
×
Clear all
No trials found.